These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19869869)

  • 41. FURTHER STUDIES ON BACTERIAL HYPERSUSCEPTIBILITY. II.
    Zinsser H; Parker JT
    J Exp Med; 1923 Jan; 37(2):275-302. PubMed ID: 19868726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. STUDIES ON PNEUMOCOCCUS IMMUNITY : III. THE NATURE OF PNEUMOCOCCUS ANTIGEN.
    Perlzweig WA; Steffen GI
    J Exp Med; 1923 Jul; 38(2):163-82. PubMed ID: 19868781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunochemical studies on the specific polysaccharide of type II Pneumococcus.
    BEISER SB; KABAT EA; SCHOR JM
    J Immunol; 1952 Sep; 69(3):297-309. PubMed ID: 13000139
    [No Abstract]   [Full Text] [Related]  

  • 44. STUDIES ON THE SOMATIC C POLYSACCHARIDE OF PNEUMOCOCCUS : II. THE PRECIPITATION REACTION IN ANIMALS WITH EXPERIMENTALLY INDUCED PNEUMOCOCCIC INFECTION.
    Abernethy TJ
    J Exp Med; 1937 Jan; 65(1):75-89. PubMed ID: 19870592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of type in capsulated transformants on pneumococcus by the genome of non-capsulated donor and recipient strains.
    JACKSON S; MACLEOD CM; KRAUSS MR
    J Exp Med; 1959 May; 109(5):429-38. PubMed ID: 13641567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphologic variation in pneumococcus. I. An analysis of the bases for morphologic variation in pneumococcus and description of a hitherto undefined morphologic variant.
    AUSTRIAN R
    J Exp Med; 1953 Jul; 98(1):21-34. PubMed ID: 13069647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous production of two capsular polysaccharides by pneumococcus. II. The genetic and biochemical bases of binary capsulation.
    AUSTRIAN R; BERNHEIMER HP; SMITH EE; MILLS GT
    J Exp Med; 1959 Oct; 110(4):585-602. PubMed ID: 13795197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The immunological specificity of type II Pneumococcus and its separation into partial specificities.
    HEIDELBERGER M; ADAMS J
    J Exp Med; 1956 Feb; 103(2):189-97. PubMed ID: 13286426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. THE ROLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I.
    Ross V
    J Exp Med; 1931 Nov; 54(6):899-923. PubMed ID: 19869967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.
    Heidelberger M; Avery OT
    J Exp Med; 1923 Jun; 38(1):73-9. PubMed ID: 19868772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AN EXAMINATION OF THE MECHANISM OF PNEUMOCOCCUS IMMUNITY BY MEANS OF BACTERICIDAL MEASUREMENTS : II. THE REACTION BETWEEN THE ANTICARBOHYDRATE ANTIBODY AND TYPE-SPECIFIC PRODUCTS OF THE ORGANISM.
    Ward HK
    J Exp Med; 1932 Mar; 55(4):519-30. PubMed ID: 19870010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. THE COMPLEMENT FIXATION REACTION WITH PNEUMOCOCCUS CAPSULAR POLYSACCHARIDE.
    Goodner K; Horsfall FL
    J Exp Med; 1936 Jul; 64(2):201-16. PubMed ID: 19870530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-alpha production by murine macrophages.
    Simpson SQ; Singh R; Bice DE
    Am J Respir Cell Mol Biol; 1994 Mar; 10(3):284-9. PubMed ID: 8117447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RESULTS OF PROPHYLACTIC INOCULATION AGAINST PNEUMOCOCCUS IN 12,519 MEN.
    Cecil RL; Austin JH
    J Exp Med; 1918 Jul; 28(1):19-41. PubMed ID: 19868242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. THE VIABILITY OF THE PNEUMOCOCCUS AFTER DRYING: A STUDY OF ONE OF THE FACTORS IN PNEUMONIC INFECTION.
    Wood FC
    J Exp Med; 1905 Aug; 7(5):592-625. PubMed ID: 19867014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fractionation and physical-chemical studies of a commercial preparation of the specific polysaccharide of type I pneumococcus.
    ALBERTY RA; HEIDELBERGER M
    J Am Chem Soc; 1948 Jan; 70(1):211-3. PubMed ID: 18918816
    [No Abstract]   [Full Text] [Related]  

  • 57. STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.
    Avery OT; Macleod CM; McCarty M
    J Exp Med; 1944 Feb; 79(2):137-58. PubMed ID: 19871359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FACTORS AFFECTING THE YIELD OF SPECIFIC ENZYME IN CULTURES OF THE BACILLUS DECOMPOSING THE CAPSULAR POLYSACCHARIDE OF TYPE III PNEUMOCOCCUS.
    Dubos R
    J Exp Med; 1932 Feb; 55(3):377-91. PubMed ID: 19869997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. POLYSACCHARIDE AND GLYCOLIPID SYNTHESIS BY CELL-FREE PREPARATIONS FROM TYPE XIV PNEUMOCOCCUS.
    DISTLER J; ROSEMAN S
    Proc Natl Acad Sci U S A; 1964 May; 51(5):897-905. PubMed ID: 14173009
    [No Abstract]   [Full Text] [Related]  

  • 60. The type-specific substance from Pneumococcus type 11A(43).
    Kennedy DA; Buchanan JG; Baddiley J
    Biochem J; 1969 Oct; 115(1):37-45. PubMed ID: 4390773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.